Sotera Health

SHC | NASDAQ

Price Alert Chart Builder DCF Calculator

$18.70

-$0.03 (-0.16%)

At close: Sep 21, 2026, 4:00 PM ET

$18.44

-$0.26 (-1.39%)

After-hours: Sep 21, 2026, 7:56 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $5.34B

Enterprise Value $7.24B

Beta 1.78

Average Volume 3.16M

Shares Outstanding (Diluted) 288.15M

Shares Change YoY 0.84%

Institutional Ownership 96.74%

Exchange NASDAQ

ISIN US83601L1026

Price Performance

Price Change 1M -4.0%

Price Change 3M 18.1%

Price Change 6M 36.5%

Price Change YTD 5.7%

Price Change 1Y 15.9%

Price Change 3Y 21.6%

Price Change 5Y -28.5%

1M CAGR (ann.) -0.9%

1Y CAGR (ann.) 15.3%

5Y CAGR (ann.) -5.5%

All-Time CAGR -4.9%

Valuation

PE Ratio 32.81

Forward PE 17.43

PEG Ratio 0.06

Forward PEG 3.56

PS Ratio 4.38

Forward PS 4.00

PB Ratio 8.01

P/FCF Ratio 55.56

P/Adj. FCF Ratio 119.97

P/OCF Ratio 18.33

EV/Sales 5.96

EV/EBIT 17.78

EV/EBITDA 13.43

EV/FCF 75.48

Earnings Yield 3.0%

FCF Yield 1.8%

Adj. FCF Yield 0.8%

Financial Health

Net Debt $1.91B

Total Debt $2.27B

Cash & Short-Term Investments $356.73M

Total Assets $3.31B

Current Ratio 2.80

Quick Ratio 2.53

Debt / Equity Ratio 3.41

Debt / EBITDA 4.20

Debt / FCF 23.63

OCF / Debt 0.14

Interest Coverage 3.07

Altman Z-Score 1.95

Piotroski F-Score 7

Margins & Profitability

Gross Profit Margin 54.7%

Operating Profit Margin 36.2%

EBITDA Margin 44.4%

Net Profit Margin 13.4%

FCF Margin 7.9%

Adj. FCF Margin 3.6%

SBC / Revenue 3.0%

SBC Impact (per share) -53.7%

Returns

Return on Assets 4.9%

Return on Equity 26.8%

Return on Invested Capital 8.8%

Return on Capital Employed 14.3%

Return on Tangible Assets 8.4%

Historical Growth (CAGR)

Revenue CAGR 3Y 7.6%

Revenue CAGR 5Y 6.7%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 81.2%

EPS CAGR 5Y 95.4%

EPS CAGR 10Y N/A

FCF CAGR 3Y 39.9%

FCF CAGR 5Y -5.5%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 12

EPS Growth Next 3Y 30.6%

Revenue Growth Next 3Y 6.8%

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $5.47

Graham Upside -70.8%

Lynch Fair Value $14.25

Lynch Upside -23.8%

Price Target $20.50

Price Target Upside 9.6%

Cash Flow

Operating Cash Flow $321.62M

Free Cash Flow $95.97M

Adj. Free Cash Flow $44.45M

FCF Per Share $0.39

OCF Per Share $1.02

OCF/S Ratio 24.0%

Income Statement

Revenue $1.22B

Gross Profit $665.48M

Operating Income $440.73M

EBITDA $539.39M

Net Income $163.48M

EPS (Diluted) $0.57

Revenue / Employee $405.39K

Profit / Employee $54.49K

Employees 3,000